Academic Health Center
Stay Connected
research-and-clinical-trials

Should All Breast Cancer Patients Receive Adjuvant Chemotherapy Treatment?

Women who undergo surgery for breast cancer will often consider adjuvant therapy, usually a precautionary regimen of chemotherapy to ensure the cancer is totally gone. For the most common types of breast cancer, this approach was believed to contribute to better long-term outcomes. But new research in the journal Cancer show it may not provide benefits for certain subtypes of breast cancer.

Read more
expert-perspectives

ACA repeal could greatly impact women’s health

Since President Donald Trump’s inauguration, there has been a steady drop in the probability that the Affordable Care Act will be repealed by the end of April. A recent Washington Post poll shows a 35 percent chance of that happening. However, this does not quell the fears raised by what a repeal could mean.

Read more
expert-perspectives

Cervical cancer is killing more women than medical experts thought, study says

“In my opinion, the study’s most disturbing revelation was this: black women living in the United States die at the same rate from cervical cancer as women living in sub-Saharan Africa,” said Christopher Pennell, Ph.D., associate director for Community Engagement at the Masonic Cancer Center, University of Minnesota, referring to a recent study about cervical cancer. “If this isn’t a wake-up call, I don’t know what is.”

Read more
expert-perspectives

What Obamacare repeal could mean for health disparities in Minnesota

18 million people – that’s how many people would be left uninsured within the first year if Obamacare is repealed, according to the Congressional Budget Office. The nonpartisan federal agency also projected within 10 years, 32 million more people would be without health insurance.

Read more
expert-perspectives

Expert Perspective: 1-in-4 U.S. men has HPV strains linked to cancer

Last week, a study published in JAMA Oncology revealed one in four men in the U.S. are infected with human papilloma virus (HPV). And, that’s just the people with the cancer-causing strains.

HPV is the leading cause of cervical cancer in women, and also a leading cause of anal and oropharyngeal cancers, especially in men.

Annie-Laurie McRee, Dr.P.H., assistant professor in the Medical School, weighs in on the data.

Read more
news-and-notes

U joins national partnership aimed at expanding biopharmaceutical workforce and industry

The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a public-private partnership supported by a $70M investment from the National Institute of Standards and Technology and at least $129M from other participants, aims to transform biopharmaceutical manufacturing in the U.S.

Read more